Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Vloga matičnih celic pri napredovanju in zdravljenju glioma
ID
Robič, Mateja
(
Author
),
ID
Motaln, Helena
(
Author
),
ID
Verbovšek, Urška
(
Author
),
ID
Lah Turnšek, Tamara
(
Author
)
URL - Presentation file, Visit
http://ojs.szd.si/index.php/vestnik/article/view/1753/1402
Image galllery
Abstract
The concepts of tumour origin and stochastic nature of carcinogenesis are being challenged today by hierarchical models that predict the existence of cancer stem cells (CSCs), which are postulated as unique cell population capable of infinite self renewal, multilineage differentiation and having a higher resistance to conventional cancer therapy thus facilitating malignant growth and therapy resistance. Accordingly, successful treatment of adult brain tumourglioma and its most malignant stageglioblastoma multiforme (GBM), would require the elimination of CSCs to avoid tumour relapse. Yet, with available therapy (i.e. surgery) in GBMs this cannot be achieved, due to infiltrative growth of a subpopluation of GBM cells with highly expressed migratory genes (migratome) into the normal brain tissue. Besides CSCs a proven prerequisite for tumour development and progression, tumour bulk mass also comprises haematopoietic stem cells, endothelial progenitor cells and mesenchymal stem cells (MSCs). The role of these other types of stem cell was shown to largely depend on the tumour microenvironment, where their contradictory anti-tumour action was evidenced. Yet, the exact mechanisms and MSCs role in cell-mediated modulation of tumour behaviour via paracrine and direct interactions with GBM (stem) cells still remain unknown. Nevertheless these stem cells, particularly MSCs, may represent novel therapeutic vectors for enhanced target-site delivery of chemotherapeutics, which are urgently needed to improve efficiency of current glioma treatment. So far, cell therapy using MSCs appears promising, due to MSCs selective tumour tropism and their immuno-modulatory potential regarding treatment of GBM, which will be discussed in this review.
Language:
Slovenian
Keywords:
tumorske matične celice
,
mezenhimske matične celice
,
mikrookolje tumorja
,
celična terapija
Work type:
Not categorized
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
Year:
2013
Number of pages:
Str. 113-122
Numbering:
Letn. 82, št. 2
PID:
20.500.12556/RUL-37719
UDC:
576
ISSN on article:
1318-0347
COBISS.SI-ID:
2802255
Publication date in RUL:
10.07.2015
Views:
1817
Downloads:
362
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Zdravniški vestnik : glasilo Slovenskega zdravniškega društva
Publisher:
Slovensko zdravniško društvo
ISSN:
1318-0347
COBISS.SI-ID:
32893696
Secondary language
Language:
English
Title:
The role of stem cells in glioma progression and therapy
Keywords:
tumour stem cells
,
mesenchymal stem cells
,
tumour micro-environment
,
cell therapy
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back